Antibiotic resistance to Propionobacterium acnes: worldwide scenario, diagnosis and management

References

• Coates P, Vyakrnam S, Eady EA, et al. Prevalence of antibiotic-resistant propionibacteria on the skin of acne patients: 10-year surveillance data and snapshot distribution study. Br J Dermatol 2002;146(5):840-8
   PubMed Web of Science ®Google Scholar
• Ross JI, Snelling AM, Carnegie E, et al. Antibiotic-resistant acne: lessons from Europe. Br J Dermatol 2003;148:467-78
   PubMed Web of Science ®Google Scholar
• Oprica C, Nord CE. European surveillance study on the antibiotic susceptibility of Propionibacterium acnes. Clin Microbiol Infect 2005;11(3):204-13
   Google Scholar
• Dumont-Wallon G, Moyse D, Blouin E, et al. Bacterial resistance in French acne patients. Int J Dermatol 2010;49(3):283-8
   Google Scholar
• Bettoli V, Borghi A, Rossi R, et al. Antibiotic resistance of propionibacteria. four years’ experience of a large number of cases in Italy. Dermatology 2006;212(2):206-7
   Google Scholar
• Hassanzadeh P, Bahmani M, Mehrabani D. Bacterial resistance to antibiotics in acne vulgaris: an in-vitro study. Indian J Dermatol 2008;53(3):122-4
   Google Scholar
• Zandi S, Vares B, Abdollahi H. Determination of microbial agents of acne vulgaris and Propionibacterium acnes antibiotic resistance in patients referred to dermatology clinics in Kerman, Iran. Jundishapur J Microbiol 2011;4(1):17-22
   Google Scholar
• Luk NM, Hui M, Lee HC, et al. Antibiotic-resistant Propionibacterium acnes among acne patients in a regional skin centre in Hong Kong. J Eur Acad Dermatol Venereol 2013;27(1):31-6
   PubMed Web of Science ®Google Scholar
• Tan HH, Tan AW, Barkham T, et al. Community-based study of acne vulgaris in adolescents in Singapore. Br J Dermatol 2007;157(3):547-51
   PubMed Web of Science ®Google Scholar
• Moon SH, Roh HS, Kim YH, et al. Antibiotic resistance of microbial strains isolated from Korean acne patients. J Dermatol 2012;39(10):833-7
   PubMed Web of Science ®Google Scholar
• Gonzalez R, Welsh O, Ocampo J, et al. In vitro antimicrobial susceptibility of Propionibacterium acnes isolated from acne patients in northern Mexico. Int J Dermatol 2010;49:1003-7
   PubMed Web of Science ®Google Scholar
• Abdel Fattah NS, Darwish YW. In vitro antibiotic susceptibility patterns of Propionibacterium acnes isolated from acne patients: an Egyptian university hospital-based study. J Eur Acad Dermatol Venereol 2013;27(12):1546-51
   PubMed Web of Science ®Google Scholar
• Nakase K, Nakaminami H, Takenaka Y, et al. relationship between the severity of acne vulgaris and antimicrobial resistance of bacteria isolated from acne lesions in a hospital of Japan. J Med Microbiol 2014;63(5):721-8
   Google Scholar
• Ishida N, Nakaminami H, Noguchi N, et al. Antimicrobial susceptibilities of Propionibacterium acnes isolated from patients with acne vulgaris. Microbiol Immunol 2008;52(12):621-4
   Google Scholar
• Toyne H, Webber C, Collignon P, et al. Propionibacterium acnes (P. acnes) resistance and antibiotic use in patients attending Australian general practice. Australas J Dermatol 2012;53(2):106-11
   Google Scholar
• Rodríguez-Cavallini E, Vargas-Dengo P. Bacterial etiology and antibiotic susceptibility in patients with acne. Rev Biomed 2004;15:101-6
   Google Scholar
• Schafer F, Fich F, Lam M, et al. Antimicrobial susceptibility and genetic characteristics of Propionibacterium acnes isolated from patients with acne. Int J Dermatol 2013;52(4):418-25
   Google Scholar
• Mendoza N, Hernandez PO, Tyring SK, et al. Antimicrobial susceptibility of Propionibacterium acnes isolates from acne patients in Colombia. Int J Dermatol 2013;52(6):688-92
   Google Scholar
• Patel JB, Cockerill FRIII, Alder J, et al. Performance standards for antimicrobial susceptibility testing; twenty-fourth informational supplement. Clinical and Laboratory Standards Institute antimicrobial susceptibility testing M100-S24 2014;34(1):1-230
   Google Scholar
• Sardana K, Garg VK. Antibiotic resistance in acne: is it time to look beyond antibiotics and Propionobacterium acnes? Int J Dermatol 2014;53(7):917-19
   Google Scholar
• Alexeyev OA, Jahns AC. Sampling and detection of skin Propionibacterium acnes: current status. Anaerobe 2012;18(5):479-83
   Google Scholar
• The European Committee on Antimicrobial Susceptibility Testing. Breakpoint tables for interpretation of MICs and zone diameters. Version 4.0. 2014. Available from: www.eucast.org
   Google Scholar
• Martin WJ, Gardner M, Washington II JA. In vitro antimicrobial susceptibility of anaerobic bacteria isolated from clinical specimens. Antimicrob Agents Chemother 1972;1:148-58
   PubMed Web of Science ®Google Scholar
• Crawford WW, Crawford IP, Stoughton RB, et al. Laboratory induction and clinical occurrence of combined clindamycin and erythromycin resistance in Corynebacterium acnes. J Invest Dermatol 1979;72:187-90
   PubMed Web of Science ®Google Scholar
• Oprica C, Löfmark S, Lund B, et al. Genetic basis of resistance in Propionibacterium acnes strains isolated from diverse types of infection in different European countries. Anaerobe 2005;11(3):137-43
   Google Scholar
• Leyden JJ, McGinley KJ, Cavalieri S, et al. Propionibacterium acnes resistance to antibiotics in acne patients. J Am Acad Dermatol 1983;8:41-5
   PubMed Web of Science ®Google Scholar
• Ross JI, Snelling AM, Eady EA, et al. Phenotypic and genotypic characterization of antibiotic-resistant Propionibacterium acnes isolated from acne patients attending dermatology clinics in Europe, the USA, Japan and Australia. Br J Dermatol 2001;144:339-46
   PubMed Web of Science ®Google Scholar
• Cunliffe WJ, Aldana OL, Goulden V. Oral trimethoprim: a relatively safe and successful third-line treatment for acne vulgaris. Br J Dermatol 2001;141:757-8
   Google Scholar
• Layton AM. Disorders of the Sebaceous Glands. In: Burns DA, Breathnach SM, Cox NH, Griffiths CEM, editors. Rook’s Textbook of Dermatology. 8th edition. Blackwell Sciences, London; 2010. 42.55-42.57
   Google Scholar
• Thiboutot D, Gollnick H, Bettoli V, et al. New insights into the management of acne: an update from the global alliance to improve outcomes in acne group. J Am Acad Dermatol 2009;60(5):S1-50
   PubMed Web of Science ®Google Scholar
• Oprica C, Emtestam L, Lapins J, et al. Antibiotic-resistant Propionibacterium acnes on the skin of patients with moderate to severe acne in Stockholm. Anaerobe 2004;10(3):155-64
   PubMed Web of Science ®Google Scholar
• Oprica C. Characterization of antibiotic-resistant Propionibacterium acnes from acne vulgaris and other diseases. Dermatology and Clinical Bacteriology. Thesis. Karolinska Institutet, Publisher Stockholm; 2006
   Google Scholar
• Zouboulis CC. Is acne vulgaris a genuine inflammatory disease? Dermatology 2001;203:277-9
   PubMed Web of Science ®Google Scholar
• Leeming JP, Holland KT, Cunliffe WJ. The microbial colonization of inflamed acne vulgaris lesions. Br J Dermatol 1988;118:203-8
   PubMed Web of Science ®Google Scholar
• Lwin SM, Kimber I, McFadden JP. Acne, quorum sensing and danger. Clin Exp Dermatol 2014;39(2):162-7
   Google Scholar
• Holland KT, Roberts CD. A technique for sampling microorganisms from the pilo-sebaceous ducts. J Appl Bacteriol 1974;37:289-96
   Google Scholar
• Otberg N, Richter H, Schaefer H, et al. Variations of hair follicle size and distribution in different body sites. J Invest Dermatol 2004;122:14-19
   PubMed Web of Science ®Google Scholar
• Rodloff AC, Hillier SL, Moncla BJ. Peptostreptococcus, Propionibacterium, Lactobacillus, Actinomycetes and other non-spore forming anaerobic Gram-positive bacteria. In: Murray PR, Baron EJ, Pfaller MA, et al. editors. Manual of clinical microbiology. American Society for Microbiology; Washington, DC: 1999. p. 672-89
   Google Scholar
• Ross JI, Eady EA, Carnegie E, et al. Detection of transposon Tn5432-mediated macrolide-lincosamide-streptogramin B (MLSB) resistance in cutaneous propionibacteria from six European cities. J Antimicrob Chemother 2002;49:165-8
   Google Scholar
• McDowell A, Barnard E, Nagy I, et al. An expanded multilocus sequence typing scheme for Propionibacterium acnes: Investigation of pathogenic, commensal and antibiotic resistant strains. PLoS One 2012;7:e41480
   PubMed Web of Science ®Google Scholar
• McDowell A, Nagy I, Magyari M, et al. The opportunistic pathogen Propionibacterium acnes: insights into typing, human disease, clonal diversification and CAMP factor evolution. PLoS One 2013;8(9):e 70897
   Google Scholar
• Scholz CF, Jensen A, Lomholt HB, et al. A Novel High-Resolution Single Locus Sequence Typing Scheme for Mixed Populations of Propionibacterium acnes In Vivo. PLoS One 2014;9(8):e 104199
   Google Scholar
• Moter A, Gobel UB. Fluorescence in situ hybridization (FISH) for direct visualization of microorganisms. J Microbiol Methods 2000;41:85e112
   Google Scholar
• Leyden JJ, McGinley KJ, Mills OH, et al. Propionibacterium levels in patients with and without acne vulgaris. J Invest Dermatol 1975;65:282-4
   Google Scholar
• Alexeyev OA, Lundskog B, Ganceviciene R, et al. Pattern of tissue invasion by Propionibacterium acnes in acne vulgaris. J Dermatol Sci 2012;67:63e6
   Google Scholar
• Jahns AC, Lundskog B, Ganceviciene R, et al. An increased incidence of Propionibacterium acnes biofilms in acne vulgaris: a case-control study. Br J Dermatol 2012;167:50-8
   PubMed Web of Science ®Google Scholar
• Alexeyev OA. Bacterial landscape of human skin: seeing the forest for the trees. Exp Dermatol 2013;22(7):443-6
   PubMed Web of Science ®Google Scholar
• Coenye T, Peeters E, Nelis HJ. Biofilm formation by Propionibacterium acnes is associated with increased resistance to antimicrobial agents and increased production of putative virulence factors. Res Microbiol 2007;158(4):386-92
   PubMed Web of Science ®Google Scholar
• Kuper KM, Boles DM, Mohr JF, et al. Antimicrobial susceptibility testing: a primer for clinicians. Pharmacotherapy 2009;29(11):1326-43
   Google Scholar
• Clinical breakpoints (Bacterial v3.1 and Fungal v6.1). The European Committee on antimicrobial susceptibility testing. Available from: www.eucast.org/clinical_breakpoints Published February 11 2013. [Accessed 4 October 2013]
   Google Scholar
• Furustrand Tafin U, Corvec S, Betrisey B, et al. Role of rifampin against Propionibacterium acnes biofilm in vitro and in an experimental foreign-body infection model. Antimicrob Agents Chemother 2012;56(4):1885-91
   PubMed Web of Science ®Google Scholar
• Pannu J, McCarthy A, Martin A, et al. In vitro antibacterial activity of NB-003 against Propionibacterium acnes. Antimicrob Agents Chemother 2011;55(9):4211-17
   Google Scholar
• Yamakawa T, Mitsuyama J, Hayashi K. In vitro and in vivo antibacterial activity of T-3912, a novel non-fluorinated topical quinolone. J Antimicrob Chemother 2002;49(3):455-65
   PubMed Web of Science ®Google Scholar
• Odou MF, Muller C, Calvet L, Dubreuil L. In vitro activity against anaerobes of retapamulin, a new topical antibiotic for treatment of skin infections. J Antimicrob Chemother 2007;59(4):646-51
   Google Scholar
• Nakatsuji T, Kao MC, Fang JY, et al. Antimicrobial property of lauric acid against Propionibacterium acnes: its therapeutic potential for inflammatory acne vulgaris. J Invest Dermatol 2009;129(10):2480-8
   PubMed Web of Science ®Google Scholar
• Gardner KJ, Cunliffe WJ, Eady EA, et al. Variation in comedonal antibiotic concentrations following applications of topical tetracycline for acne vulgaris. Br J Dermatol 1994;131:649-54
   PubMed Web of Science ®Google Scholar
• Eady AE, Cove JH, Layton AM. Is antibiotic resistance in cutaneous propionibacteria clinically relevant? : implications of resistance for acne patients and prescribers. Am J Clin Dermatol 2003;4(12):813-31
   PubMed Web of Science ®Google Scholar
• Layton AM, Hughes BR, Hull SM, et al. Seborrhoea is an indication of poor response to systemic antibiotics. Clin Exp Dermatol 1992;17:173-5
   PubMed Web of Science ®Google Scholar
• Leyden JJ, McGinley KJ, Cavalieri S, et al. Propionibacterium acnes resistance to antibiotics in acne patients. J Am Acad Dermatol 1983;8:41-5
   PubMed Web of Science ®Google Scholar
• Eady EA, Cove JH, Holland KT, et al. Erythromycin resistant propionibacteria in antibiotic treated acne patients: association with therapeutic failure. Br J Dermatol 1989;121:51-7
   PubMed Web of Science ®Google Scholar
• Oprica C, Emtestam L, Hagströmer L, et al. Clinical and microbiological comparisons of isotretinoin vs. tetracycline in acne vulgaris. Acta Derm Venereol 2007;87(3):246-54
   PubMed Web of Science ®Google Scholar
• Ozolins M, Eady EA, Avery AJ, et al. Comparison of five antimicrobial regimens for treatment of mild to moderate inflammatory facial acne vulgaris in the community: randomised controlled trial. Lancet 2004;364(9452):2188-95
   PubMed Web of Science ®Google Scholar
• Dreno B, Thiboutot D, Gollnick H, et al. Antibiotic stewardship in dermatology: limiting antibiotic use in acne. Eur J Dermatol 2014;24(3):330-4
   PubMed Web of Science ®Google Scholar
• Docherty JJ, McEwen HA, Sweet TJ, et al. Resveratrol inhibition of Propionibacterium acnes. J Antimicrob Chemother 2007;59(6):1182-4
   PubMed Web of Science ®Google Scholar
• Sardana K, Chugh S, Garg VK. The role of zinc in acne and prevention of resistance: have we missed the “base” effect? Int J Dermatol 2014;53(1):125-7
   Google Scholar
• Holland KT, Bojar RA. The effect of azelaic acid on cutaneous bacteria. J Dermatol Treat 1989;1:17-19
   Google Scholar
• Dreno B, Foulc P, Reynaud A, et al. Effect of zinc gluconate on propionibacterium acnes resistance to erythromycin in patients with inflammatory acne: in vitro and in vivo study. Eur J Dermatol 2005;15(3):152-5
   Google Scholar
• Burkhart CG, Burkhart CN. Expanding the microcomedone theory and acne therapeutics: Propionibacterium acnes biofilm produces biological glue that holds corneocytes together to form plug. J Am Acad Dermatol 2007;57:722-4
   PubMed Web of Science ®Google Scholar
• Hoeffler U, Ko HL, Pulverer G. Antimicrobiol susceptibility of Propinibacterium acnes and related microbial species. Antimicrob Agents Chemother 1976;10:387-94
   Google Scholar
• Mory F, Fougnot S, Rabaud C, et al. In vitro activities of cefotaxime, vancomycin, quinupristin/dalfopristin, linezolid and other antibiotics alone and in combination against Propionibacterium acnes isolates from central nervous system infections. J Antimicrob Chemother 2005;55(2):265-8
   Google Scholar
• Kawada A, Wada T, Oiso N. Clinical effectiveness of once-daily levofloxacin for inflammatory acne with high concentrations in the lesions. J Dermatol 2012;39(1):94-6
   Google Scholar
• Kawada A, Aragane Y, Tezuka T. Levofloxacin is effective for inflammatory acne and achieves high levels in the lesions: an open study. Dermatolog 2002;204(4):301-2
   Google Scholar
• Del Rosso JQ. Recently approved systemic therapies for acne vulgaris and rosacea. Cutis 2007;80:113-20
   PubMed Web of Science ®Google Scholar
• Amin K, Riddle CC, Aires DJ, et al. Common and alternate oral antibiotic therapies for acne vulgaris: a review. J Drugs Dermatol 2007;6(9):873-80
   Google Scholar
• Del Rosso JQ. A status report on the use of subantimicrobial-dose doxycycline: a review of the biologic and antimicrobial effects of the tetracyclines. Cutis 2004;74(2):118-22
   PubMed Web of Science ®Google Scholar
• Skidmore R, Kovach R, Walker C, et al. Effects of subantimicrobial-dose doxycycline in the treatment of moderate acne. Arch Dermatol 2003;139(4):459-64
   PubMed Web of Science ®Google Scholar
• Toossi P, Farshchian M, Malekzad F, et al. Subantimicrobial-dose doxycycline in the treatment of moderate facial acne. J Drugs Dermatol 2008;7(12):1149-52
   PubMedGoogle Scholar
• Sardana K, Garg VK. Low-dose isotretinoin in acne vulgaris: a critical review. Br J Dermatol 2011;165(3):698-700
   PubMed Web of Science ®Google Scholar
• Zander E, Weisman S. Treatment of acne vulgaris with salicylic acid pads. Clin Ther 1992;14(2):247-53
   Google Scholar
• Wiechers JW, Rawlings AV, Lindner N, et al. Treating acne with octadecenedioic acid: mechanism of action, skin delivery and clinical results, Chapter 12 In: Webster GF, Rawlings AV, editors. Acne and its therapy. Informa Healthcare; New York: 2007. p. 137-54
   Google Scholar
• Pavicic T, Wollenweber U, Farwick M, et al. Antimicrobial and anti-inflammatory activity of phytosphingosine: an in vitro and in vivo study addressing acne vulgaris. Int J Cosmet Sci 2007;29:181-90
   PubMedGoogle Scholar
• Eady EA. Bacterial resistance in acne. Dermatology 1998;196:59-66
   PubMed Web of Science ®Google Scholar
• Cohen M. Epidemiology of drug resistance: implications for a post-antimicrobial era. Science 1992;257:1050-5
   PubMed Web of Science ®Google Scholar
• Levy RM, Huang EY, Roling D, et al. Effect of antibiotics on the oropharyngeal flora in patients with acne. Arch Dermatol 2003;139:467-71
   PubMedGoogle Scholar
• Margolis DJ, Bowe WP, Hoffstad O, et al. Antibiotic treatment of acne may be associated with upper respiratory tract infections. Arch Dermatol 2005;141:1132-6
   PubMed Web of Science ®Google Scholar
• Del Rosso JQ, Leyden JJ, Thiboutot D, et al. Antibiotic use in acne vulgaris and rosacea: clinical considerations and resistance issues of significance to dermatologists. Cutis 2008;82: suppl 2[ii] 5-12
   PubMed Web of Science ®Google Scholar
• Leyden JJ, Del Rosso JQ, Webster GF. Clinical considerations in the treatment of acne vulgaris and other inflammatory skin disorders: focus on antibiotic resistance. Dermatol Clin 2009;27(1):1-15
   Google Scholar
• Bowe WP. Antibiotic resistance and acne: where we stand and what the future holds. J Drugs Dermatol 2014;13(6):s66-70
   Google Scholar
• Coates T, Eady A, Cove J. Propionibacterial biofi lms cannot explain antibiotic resistance but might contribute to some cases of antibiotic recalcitrant acne. Br J Dermatol 2003;148:366-7
   Google Scholar
• Dreno B, Bettoli V, Ochsendorf F, et al. European recommendations on the use of oral antibiotics for acne. Eur J Dermatol 2004;14:391-9
   PubMed Web of Science ®Google Scholar
• Aslam I, Fleischer A, Feldman S. Emerging drugs for the treatment of acne. Expert Opin Emerg Drugs 2014;4:1-11
   Google Scholar